SEGRO plc (the Company)
Director and PDMRs' Shareholding
The Company has been advised by Appleby Trust (Jersey) Limited (the Trustees)
of the SEGRO plc 1994 Employees' Benefit Trust (the Trust) that today, 248,665
ordinary shares of 10 pence each (the Shares) were released to participants
under the terms of the SEGRO plc Long Term Incentive Plan (the LTIP). With the
exception of David Sleath, the participants listed below sold a total of 19,106
Shares at a price of 309.728 pence per Share to meet their Income Tax
liabilities and National Insurance contributions. Following the LTIP vesting,
the total number of shares held in the Trust is 882,305.
Details of the number of Shares received by the Director and PDMRs are set out
below:-
Director Number of Number of Total beneficial shareholding
Shares Shares sold following vesting
vesting
David Sleath 22,398 - 105,925
PDMRs
Elizabeth Blease 5,313 2,769 6,372
Andy Gulliford 12,158 6,335 37,900
Gareth Osborn 9,598 5,001 24,732
Phil Redding 9,598 5,001 38,215
Robin Healy
Deputy Company Secretary
020 7451 9082
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.